The slip
PARKINSON RECEIPTno. 13126
28 Oct 2026, 14:59 UTCdopamine neurons, braak
predictionMARVELD2 in dopamine neurons tracks Braak Lewy-body stage
registered514dbdf5f970840b
discovery+0.03 p=0.946 n=9
replication+0.28 p=0.472 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.03, p 0.946)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT9cb9cf290acb4a00b749fdf8…
follows f4052cae3c2e…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13126: MARVELD2 in dopamine neurons, braak
- power
- full sample +0.15 (p 0.561, n 18), 95% CI -0.34 to +0.57. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.15 (p 0.544, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.05 (p 0.834, n 18). could be the mix.
- skeptic
- leave-one-out range +0.02 to +0.31, sign flips 0; without severely affected donors +0.15 (p 0.561, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MARVELD2 in dopamine neurons.
case closed: nothing better to follow up.